1 results
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Total dose should ... Neutropenia 2-7% Alternative ... anti-IL6 mAb) #AntiIL6 ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications